Long Covid Antibody Spectrum Test
Attomarker is developing a breakthrough diagnostic solution for Long Covid: the Long Covid Antibody Spectrum Test. The test is expected to receive UKCA Mark approval imminently and will represent a significant step in helping to understand why an individual has Long Covid and what therapeutic options may provide benefit.
How Healthcare Professionals Can Get Involved
Join us in transforming the way Long Covid is diagnosed and managed:
Stay Informed
Subscribe to receive updates on our latest developments, including the UKCA Mark approval and launch of the Long Covid Antibody Spectrum Test, and evolving developments in understanding both the condition and treatment options.
Participate in Research
Collaborate with Attomarker to advance research on Long Covid and its underlying mechanisms.
Join the Referral Network
Become a trusted partner in offering the Long Covid Antibody Spectrum Test to your patients. As part of our referral network, you’ll play a vital role in ensuring patients receive the diagnostics they need.
Keep Updated
Check out our LinkedIn for the latest updates on Attomarker including our Company Announcements, Investor Announcement and product launches.